<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Metabolomics is coming of age as an important area of investigation which may help reveal answers to questions left unanswered or only partially understood from proteomic or genomic approaches </plain></SENT>
<SENT sid="1" pm="."><plain>Increased knowledge of the relationship of genes and proteins to smaller biomolecules (metabolites) will advance our ability to diagnose, treat, and perhaps prevent <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and other diseases that have eluded scientists for generations </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">Colorectal tumors</z:e> are the second leading cause of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> mortality in the USA, and the incidence is rising </plain></SENT>
<SENT sid="3" pm="."><plain>Many patients present late, after the <z:hpo ids='HP_0003674'>onset</z:hpo> of symptoms, when the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> has spread from the primary site </plain></SENT>
<SENT sid="4" pm="."><plain>Once <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> have occurred, the prognosis is significantly worse </plain></SENT>
<SENT sid="5" pm="."><plain>Understanding alterations in metabolic profiles that occur with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:hpo ids='HP_0003674'>onset</z:hpo> and progression could lead to better diagnostic tests as well as uncover new approaches to treat or even prevent <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="6" pm="."><plain>In this review, we explore the various analytical technologies that have been applied in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> metabolomics research and summarize <z:hpo ids='HP_0000001'>all</z:hpo> metabolites measured in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and integrate them into metabolic pathways </plain></SENT>
<SENT sid="7" pm="."><plain>Early studies with nuclear magnetic resonance and gas-chromatographic mass spectrometry suggest that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells are characterized by aerobic glycolysis, increased <z:chebi fb="0" ids="35584">purine</z:chebi> metabolism for DNA synthesis, and protein synthesis </plain></SENT>
<SENT sid="8" pm="."><plain>Liquid chromatography, capillary electrophoresis, and ion mobility, each coupled with mass spectrometry, promise to advance the field and provide new insight into metabolic pathways used by <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="9" pm="."><plain>Studies with improved technology are needed to identify better biomarkers and targets for treatment or prevention of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>